113 related articles for article (PubMed ID: 38600718)
1. Construction and validation of key genes-related prognosis model in children with acute myeloid leukaemia.
Huang F; Ming C; Jiang Y; Li C; Tan C
Int J Lab Hematol; 2024 Apr; ():. PubMed ID: 38600718
[TBL] [Abstract][Full Text] [Related]
2. DesA Prognostic Risk Model of LncRNAs in Patients With Acute Myeloid Leukaemia Based on TCGA Data.
Ding W; Ling Y; Shi Y; Zheng Z
Front Bioeng Biotechnol; 2022; 10():818905. PubMed ID: 35265597
[No Abstract] [Full Text] [Related]
3. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
4. SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients.
Liu F; Deng S; Li Y; Du J; Zeng H
Front Genet; 2022; 13():1081262. PubMed ID: 36685828
[No Abstract] [Full Text] [Related]
5. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
Front Oncol; 2022; 12():966920. PubMed ID: 36276132
[TBL] [Abstract][Full Text] [Related]
6. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases.
Chen P; Cao J; Chen L; Gao G; Xu Y; Jia P; Li Y; Li Y; Du J; Zhang S; Zhang J
Cancer Biomark; 2023; 36(4):287-298. PubMed ID: 36938728
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.
Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y
J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393
[TBL] [Abstract][Full Text] [Related]
11. A six-gene-based prognostic model predicts complete remission and overall survival in childhood acute myeloid leukemia.
Zhang N; Chen Y; Lou S; Shen Y; Deng J
Onco Targets Ther; 2019; 12():6591-6604. PubMed ID: 31496748
[TBL] [Abstract][Full Text] [Related]
12. A three-gene signature and clinical outcome in pediatric acute myeloid leukemia.
Cai Z; Wu Y; Zhang F; Wu H
Clin Transl Oncol; 2021 Apr; 23(4):866-873. PubMed ID: 32862280
[TBL] [Abstract][Full Text] [Related]
13. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
[TBL] [Abstract][Full Text] [Related]
14. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract][Full Text] [Related]
15. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
16. Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients.
Eshibona N; Livesey M; Christoffels A; Bendou H
Front Genet; 2023; 14():1131159. PubMed ID: 36865386
[No Abstract] [Full Text] [Related]
17. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
[TBL] [Abstract][Full Text] [Related]
18. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
19. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
20. A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia.
Liu X; Wang L; Kang Q; Feng C; Wang J
Front Pharmacol; 2024; 15():1339465. PubMed ID: 38482057
[No Abstract] [Full Text] [Related]
[Next] [New Search]